Zacks Research Has Bearish Estimate for Nutrien Q4 Earnings

Nutrien Ltd. (NYSE:NTR) – Analysts at Zacks Research lowered their Q4 2024 earnings per share (EPS) estimates for Nutrien in a research report issued to clients and investors on Tuesday, November 19th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.38 for the quarter, down from their previous forecast of $0.51. The consensus estimate for Nutrien’s current full-year earnings is $3.59 per share. Zacks Research also issued estimates for Nutrien’s Q1 2025 earnings at $0.31 EPS, Q2 2025 earnings at $1.97 EPS, Q4 2025 earnings at $0.72 EPS and FY2025 earnings at $3.54 EPS.

A number of other research firms have also weighed in on NTR. Wells Fargo & Company lowered shares of Nutrien from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $62.00 to $50.00 in a report on Tuesday, September 24th. Scotiabank dropped their target price on Nutrien from $66.00 to $59.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th. Royal Bank of Canada reiterated an “outperform” rating and issued a $60.00 price target on shares of Nutrien in a research note on Friday, September 20th. Barclays lowered their price objective on Nutrien from $68.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, August 16th. Finally, The Goldman Sachs Group lowered Nutrien from a “buy” rating to a “neutral” rating and cut their target price for the company from $69.00 to $53.00 in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $60.33.

Nutrien Trading Up 0.1 %

NTR opened at $46.93 on Thursday. The firm’s 50 day moving average is $48.01 and its 200-day moving average is $50.18. Nutrien has a 52-week low of $44.65 and a 52-week high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $23.18 billion, a P/E ratio of 31.50, a P/E/G ratio of 1.59 and a beta of 0.82.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). The company had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.35 earnings per share.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be issued a $0.939 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 annualized dividend and a dividend yield of 8.00%. Nutrien’s payout ratio is 144.97%.

Hedge Funds Weigh In On Nutrien

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Silchester International Investors LLP lifted its holdings in shares of Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock worth $513,437,000 after purchasing an additional 6,642,075 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Nutrien in the third quarter worth $150,181,000. Bank of Montreal Can lifted its stake in Nutrien by 15.5% in the second quarter. Bank of Montreal Can now owns 13,354,385 shares of the company’s stock valued at $719,668,000 after buying an additional 1,794,333 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock valued at $121,271,000 after buying an additional 1,100,000 shares during the last quarter. Finally, National Bank of Canada FI boosted its holdings in shares of Nutrien by 34.0% during the second quarter. National Bank of Canada FI now owns 4,066,629 shares of the company’s stock valued at $205,385,000 after acquiring an additional 1,032,763 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.